Polyethylene Glycol 3350, powder, for solution 527g BRE, Rx Only, 28 days supply, NDC 51991-0457-57
Reason Lack of Processing Controls.
37 FDA recalls mention Polyethylene. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Polyethylene.
Reason Lack of Processing Controls.
Reason Presence of Particulate Matter
Reason Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
Reason CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.
Reason CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.
Reason Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients…
Reason Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients…
Reason Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients…
Reason Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients…
Reason Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients…
Reason Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients…
Reason Labeling: Label Mix-Up: Incorrect back labeling of the immediate container of eye drops (unit carton and front label are correct) which do not list…
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.